Haloshine 0.25mg Tablet
Marketer
Gentech Healthcare Pvt Ltd
Salt Composition
Haloperidol (0.25mg)
Overview Haloshine 0.25mg Tablet
Locazen 0.25mg tablets are indicated for managing schizophrenia, a condition characterized by distorted perceptions and behaviors. Its mechanism involves inhibiting a neurotransmitter impacting cognition and affect. Locazen 0.25mg tablets also treat psychosis, manic episodes, and severe behavioral disturbances in adults and children. Administer with or without food, consistently at the same time daily for optimal therapeutic levels. Follow your physician's prescribed dosage and duration; take missed doses promptly. Complete the entire course, even with symptom improvement, and never discontinue abruptly without consulting your doctor, as this may exacerbate symptoms. Commonly reported adverse effects include restlessness, sleeplessness, extrapyramidal symptoms, muscle stiffness, and cephalalgia. Report any concerning or worsening side effects to your doctor, who can advise on management strategies. Prior to commencing treatment, disclose any existing thyroid, renal, seizure, Parkinson's, glaucoma, or cardiac conditions. Avoid concurrent use with alcohol or sedatives, including cough and allergy medications. Weight gain is a potential consequence; maintain a balanced diet, limit high-calorie snacks, and engage in regular physical activity.
Primary Ingredients of Haloshine 0.25mg Tablet
No information provided. Unable to rephrase.
Uses of Haloshine 0.25mg Tablet
Split personality disorder
Major Benefits of Haloshine 0.25mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 0.25mg Haloshine tablet whole; do not break, crush, or chew it. While you can take it with or without food, consistent timing is recommended.
Common Side effects of Haloshine 0.25mg Tablet:
- Agitation
- Extrapyramidal symptoms
- Insomnia (difficulty in sleeping)
- Muscle spasm
- Headache
How to use Haloshine 0.25mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Haloshine 0.25mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Haloshine 0.25mg Tablet works:
This medication, Haloshine 0.25mg Tablet, is a standard antipsychotic drug. Its mechanism involves inhibiting dopamine, a neurotransmitter influencing cognitive function and emotional state.
SAFETY ADVICE
AlcoholUNSAFE
Taking Haloshine 0.25mg tablets with alcohol may result in significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Haloshine 0.25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Haloshine 0.25mg tablets while breastfeeding is likely inadvisable. Studies in humans indicate potential transfer of the medication into breast milk, posing a possible risk to the infant. Should Haloshine 0.25mg tablets be necessary, careful observation of the baby for increased drowsiness is recommended.
DrivingUNSAFE
Taking Haloshine 0.25mg tablets might cause drowsiness, blurred vision, and dizziness. Driving is inadvisable if you experience these effects.
KidneySAFE IF PRESCRIBED
Haloshine 0.25mg tablets are considered safe for use in individuals with kidney disease, and no dosage modification is typically necessary. Nevertheless, patients exhibiting severe kidney impairment might require initiation at a reduced dose due to a potential increased risk of somnolence.
LiverCAUTION
Patients with liver impairment should use Haloshine 0.25mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Haloshine 0.25mg Tablet :
NA
Facts to Know About Haloshine 0.25mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Butyrophenone Analog |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Behavior Class | Conventional Antipsychotics |
3,018 People bought this recently